KEY FEATURES
| Full Name | V-Myc Myelocytomatosis Viral Oncogene Homolog |
|---|---|
| Synonym | C-Myc; BHLHE39; Myc Proto-Oncogene Protein; VMyc Class E basic helix-loop-helix protein 39; Transcription factor p64; Proto-oncogene c-Myc |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 1.56-100ng/mL |
| Sensitivity | 0.55ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human MYC in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human MYC. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human MYC and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human MYC, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human MYC. You can calculate the concentration of Human MYC in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human MYC ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 5.34 | 11.15 | 41.4 | 5.42 | 10.55 | 44.92 |
| Standard deviation | 0.35 | 0.48 | 1.83 | 0.38 | 0.48 | 2.42 |
| CV(%) | 6.5 | 4.29 | 4.43 | 6.95 | 4.56 | 5.38 |
RECOVERY
The recovery of Human MYC spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 95-109 | 101 |
| EDTA plasma (n=8) | 92-104 | 98 |
| Cell culture media (n=8) | 84-99 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human MYC in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with NMI ELISA Kits
| MYC ELISA Kit | publications with NMI and MYC |
| STAT1 ELISA Kit | publications with NMI and STAT1 |
| IFI35 ELISA Kit | publications with NMI and IFI35 |
| SOX10 ELISA Kit | publications with NMI and SOX10 |
| MYCN ELISA Kit | publications with NMI and MYCN |
| STAT5B ELISA Kit | publications with NMI and STAT5B |
| BRCA1 ELISA Kit | publications with NMI and BRCA1 |
Pathways associated with NMI ELISA Kit
| IL-2 Signaling Pathway | IL-2 Signaling Pathway |
Diseases associated with NMI ELISA Kit
| Neoplasms | publications with NMI and Neoplasms |
| Cardiovascular Diseases | publications with NMI and Cardiovascular Diseases |
| Urinary Bladder Neoplasms | publications with NMI and Urinary Bladder Neoplasms |
| Brain Diseases | publications with NMI and Brain Diseases |
| Learning Disorders | publications with NMI and Learning Disorders |
| Pain | publications with NMI and Pain |
| Vascular Diseases | publications with NMI and Vascular Diseases |
| Myocardial Ischemia | publications with NMI and Myocardial Ischemia |
| Breast Neoplasms | publications with NMI and Breast Neoplasms |
| Cognition Disorders | publications with NMI and Cognition Disorders |
Organs/Tissues associated with NMI ELISA Kit
| Blood | publications with NMI and Blood |
| Muscle | publications with NMI and Muscle |
| Brain | publications with NMI and Brain |
| Bladder | publications with NMI and Bladder |
| Vascular | publications with NMI and Vascular |
| Eye | publications with NMI and Eye |
| Liver | publications with NMI and Liver |
| Lung | publications with NMI and Lung |
| Kidney | publications with NMI and Kidney |
| Bone | publications with NMI and Bone |